Amiglyde-V 250mg Injection 48ml

Prescription items are NON-RETURNABLE and NON REFUNDABLE

Amiglyde-V Intrauterine Solution Indications

AMIGLYDE-V is indicated for the treatment of uterine infections (endometritis, metritis and pyometra) in mares, when caused by susceptible organisms including Escherichia coli, Pseudomonas sp and Klebsiella sp. The use of AMIGLYDE-V in eliminating infections caused by the above organisms has been shown clinically to improve fertility in infected mares.

While nearly all strains of Escherichia coli, Pseudomonas sp and Klebsiella sp, including those that are resistant to gentamicin, kanamycin or other aminoglycosides, are susceptible to amikacin at levels achieved following treatment, it is recommended that the invading organism be cultured and its susceptibility demonstrated as a guide to therapy. Amikacin susceptibility discs, 30 mcg, should be used for determining in vitro susceptibility.

Administration And Dosage

There are no known contraindications for the use of AMIGLYDE-V in horses other than a history of hypersensitivity to amikacin.

Precautions

Although AMIGLYDE-V is not absorbed to an appreciable extent following intrauterine infusion, concurrent use of other aminoglycosides should be avoided because of the potential for additive effects.

Adverse Reactions

No adverse reactions or other side effects have been reported.

Warning

Do not use in horses intended for human consumption.

In vitro studies have demonstrated that when sperm are exposed to the preservative which is present in the 48 mL vials (250 mg/mL) sperm viability is impaired.

Supply

AMIGLYDE-V (amikacin sulfate injection) Veterinary Solution is supplied as a colorless solution which is stable when stored at or below 25°C (77°F). Use contents within 3 months of first vial puncture.

48 mL vial, 250 mg/mL

Store at or below 25°C (77°F).